Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microglia in Parkinson’s Disease
Margaret S. Ho
Advances in experimental medicine and biology (2019), pp. 335-353
Closed Access | Times Cited: 190

Showing 1-25 of 190 citing articles:

The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Qing Wang, Yuqi Luo, К. Ray Chaudhuri, et al.
Brain (2021) Vol. 144, Iss. 9, pp. 2571-2593
Open Access | Times Cited: 187
Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome
Takumi Satoh, Dorit Trudler, Chang-ki Oh, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 124-124
Open Access | Times Cited: 92
Copper induces microglia-mediated neuroinflammation through ROS/NF-κB pathway and mitophagy disorder
Qian Zhou, Ying Zhang, Lu Lu, et al.
Food and Chemical Toxicology (2022) Vol. 168, pp. 113369-113369
Closed Access | Times Cited: 82
Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s disease
Qiankun Lv, Kang‐Xin Tao, Xiaobo Wang, et al.
Inflammation Research (2023) Vol. 72, Iss. 3, pp. 443-462
Closed Access | Times Cited: 50
Puerarin: a potential natural neuroprotective agent for neurological disorders
Xue Liu, Rui Huang, Jiye Wan
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114581-114581
Open Access | Times Cited: 46
Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Caiyun Liu, Xu Wang, Chang Liu, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 114
Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration
Jingyi He, Guofu Zhu, Guoqing Wang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 91
Corynoxine Protects Dopaminergic Neurons Through Inducing Autophagy and Diminishing Neuroinflammation in Rotenone-Induced Animal Models of Parkinson’s Disease
Leilei Chen, Yujv Huang, Yu Xing, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 71
Ferritinophagy‐Mediated Ferroptosis Involved in Paraquat‐Induced Neurotoxicity of Dopaminergic Neurons: Implication for Neurotoxicity in PD
Yong Zuo, Jinhong Xie, Xincheng Li, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 70
Kaemperfol alleviates pyroptosis and microglia-mediated neuroinflammation in Parkinson's disease via inhibiting p38MAPK/NF-κB signaling pathway
Meiyun Cai, Wenxin Zhuang, Elagina Lv, et al.
Neurochemistry International (2021) Vol. 152, pp. 105221-105221
Closed Access | Times Cited: 68
The immunology of Parkinson’s disease
Biqing Zhu, Dominic Yin, Hongyu Zhao, et al.
Seminars in Immunopathology (2022) Vol. 44, Iss. 5, pp. 659-672
Open Access | Times Cited: 55
Ginsenoside Rg1 Reduced Microglial Activation and Mitochondrial Dysfunction to Alleviate Depression-Like Behaviour Via the GAS5/EZH2/SOCS3/NRF2 Axis
Junnan Li, Wei Gao, Zhonghui Zhao, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 5, pp. 2855-2873
Open Access | Times Cited: 53
Transmembrane protein 119 is neither a specific nor a reliable marker for microglia
Elise Vankriekelsvenne, Uta Chrzanowski, Katerina Manzhula, et al.
Glia (2022) Vol. 70, Iss. 6, pp. 1170-1190
Open Access | Times Cited: 50
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Giuseppe Arena, Karan Sharma, Gideon Agyeah, et al.
Current Neurology and Neuroscience Reports (2022) Vol. 22, Iss. 8, pp. 427-440
Open Access | Times Cited: 48
Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns
Natalia Madetko‐Alster, Bartosz Migda, Piotr Alster, et al.
Neurologia i Neurochirurgia Polska (2022) Vol. 56, Iss. 2, pp. 148-155
Open Access | Times Cited: 43
Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
Shuanglong Yi, Linfang Wang, Honglei Wang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14753-14753
Open Access | Times Cited: 41
Different Methods for Evaluating Microglial Activation Using Anti-Ionized Calcium-Binding Adaptor Protein-1 Immunohistochemistry in the Cuprizone Model
Mariela Wittekindt, Hannes Kaddatz, Sarah Joost, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1723-1723
Open Access | Times Cited: 38
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
Peter Riederer, Toshiharu Nagatsu, Moussa B. H. Youdim, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 5, pp. 627-646
Open Access | Times Cited: 35
Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy
Amber D. Van Laar, Katherine R. Webb, Matthew T. Keeney, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 27
An Antisense Oligonucleotide-Loaded Blood–Brain Barrier Penetrable Nanoparticle Mediating Recruitment of Endogenous Neural Stem Cells for the Treatment of Parkinson’s Disease
Yuting Sun, Jianglong Kong, Xiaohan Ge, et al.
ACS Nano (2023) Vol. 17, Iss. 5, pp. 4414-4432
Closed Access | Times Cited: 26
The role of CD56bright NK cells in neurodegenerative disorders
Carla Rodriguez-Mogeda, Chaja M. J. van Ansenwoude, Lennart van der Molen, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
The Misfolding Mystery: α-syn and the Pathogenesis of Parkinson's Disease
Samir Negi, Navneet Khurana, Navneet Duggal
Neurochemistry International (2024) Vol. 177, pp. 105760-105760
Closed Access | Times Cited: 11
The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, et al.
Journal of Neuroimmunology (2021) Vol. 361, pp. 577758-577758
Open Access | Times Cited: 55
More Than Mortar: Glia as Architects of Nervous System Development and Disease
Inês Lago‐Baldaia, Vilaiwan M. Fernandes, Sarah D. Ackerman
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 54
Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson’s disease: Potential clinical and therapeutic implications
Efthalia Angelopoulou, Yam Nath Paudel, Mohd. Farooq Shaikh, et al.
Pharmacological Research (2020) Vol. 158, pp. 104930-104930
Closed Access | Times Cited: 52
Page 1 - Next Page

Scroll to top